Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2020
  2. Published

    Neoadjuvant chemotherapy and HER2 dual blockade including biosimilar trastuzumab (SB3) for HER2-positive early breast cancer: Population based real world data from the Danish Breast Cancer Group (DBCG)

    Berg, T., Jensen, M-B., Jakobsen, E. H., Al-Rawi, S., Kenholm, J. & Andersson, M., Dec 2020, In : Breast. 54, p. 242-247 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000-1

    Poikonen-Saksela, P., Lindman, H., Sverrisdottir, A., Edlund, P., Villman, K., Tennvall Nittby, L., Cold, S., Bechmann, T., Stenbygaard, L., Ejlertsen, B., Andersson, M., Blomqvist, C., Bergh, J. & Ahlgren, J., Jul 2020, In : Acta Oncologica. 59, 7, p. 825-832 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Dual HER2 blockade in the first-line treatment of metastatic breast cancer - A retrospective population-based observational study in Danish patients

    Christensen, T., Berg, T., Nielsen, L. B., Andersson, M., Jensen, M-B. & Knoop, A., Jun 2020, In : Breast. 51, p. 34-39 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. 2019
  6. Published
  7. 2018
  8. Published
  9. Published

    Statin use and risk of contralateral breast cancer: a nationwide cohort study

    Langballe, R., Cronin-Fenton, D., Dehlendorff, C., Jensen, M-B., Ejlertsen, B., Andersson, M., Friis, S. & Mellemkjær, L., Nov 2018, In : British Journal of Cancer. 119, 10, p. 1297-1305 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Mortality after contralateral breast cancer in Denmark

    Langballe, R., Frederiksen, K., Jensen, M-B., Andersson, M., Cronin-Fenton, D., Ejlertsen, B. & Mellemkjær, L., Sep 2018, In : Breast Cancer Research and Treatment. 171, 2, p. 489-499 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)

    Lindman, H., Andersson, M., Ahlgren, J., Balslev, E., Sverrisdottir, A., Holmberg, S. B., Bengtsson, N. O., Jacobsen, E. H., Jensen, A. B., Hansen, J., Tuxen, M. K., Malmberg, L., Villman, K., Anderson, H., Ejlertsen, B., Bergh, J., Blomqvist, C. & Swedish Breast Cancer Group (SweBCG), the Danish Breast Cancer Group (DBCG) and the Scandinavian Breast Cancer Group (SBG), May 2018, In : European journal of cancer (Oxford, England : 1990). 94, p. 79-86 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study

    Singh, S., Andersen, N. N., Andersson, M., Loftus, E. V. & Jess, T., Mar 2018, In : Alimentary Pharmacology and Therapeutics. 47, 5, p. 596-604 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes

    Spraggs, C. F., Parham, L. R., Briley, L. P., Warren, M. L., Williams, V. S. L., Fraser, D. J., Jiang, Z-M., Aziz, T. Z., Ahmed, S., Demetriou, G., Mehta, M. A., Jackson, N., Byrne, J., Andersson, M., Toi, M., Harris, A. L., Gralow, J., Zujewski, J. A., Crescenzo, R., Armour, A., Perez, E. A. & Piccart, M., 2018, In : The pharmacogenomics journal. 18, 3, p. 480-486

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    FRAX Calculated without BMD Resulting in a Higher Fracture Risk Than That Calculated with BMD in Women with Early Breast Cancer

    Prawiradilaga, R. S., Gunmalm, V., Lund-Jacobsen, T., Helge, E. W., Brøns, C., Andersson, M. & Schwarz, P., 2018, In : Journal of Osteoporosis. p. 4636028 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. 2017
  16. Published

    Checkpoint inhibitors in breast cancer - Current status

    Polk, A., Svane, I-M., Andersson, M. & Nielsen, D., 14 Dec 2017, In : Evidence-based Oncology. 63, p. 122-134 13 p.

    Research output: Contribution to journalReviewResearchpeer-review

  17. Published

    The effects of individually tailored nurse navigation for patients with newly diagnosed breast cancer: a randomized pilot study

    Mertz, B. G., Dunn-Henriksen, A. K., Kroman, N., Johansen, C., Andersen, K. G., Andersson, M., Mathiesen, U. B., Vibe-Petersen, J., Dalton, S. O. & Envold Bidstrup, P., Dec 2017, In : Acta oncologica . 56, 12, p. 1682-1689 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Efficacy and Safety of Pertuzumab and Trastuzumab Administered in a Single Infusion Bag, Followed by Vinorelbine: VELVET Cohort 2 Final Results

    Andersson, M., López-Vega, J. M., Petit, T., Zamagni, C., Easton, V., Kamber, J., Restuccia, E. & Perez, E. A., Oct 2017, In : The oncologist. 22, 10, p. 1160-1168 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial

    Ejlertsen, B., Tuxen, M. K., Jakobsen, E. H., Jensen, M-B., Knoop, A. S., Højris, I., Ewertz, M., Balslev, E., Danø, H., Vestlev, P. M., Kenholm, J., Nielsen, D. L., Bechmann, T., Andersson, M., Cold, S., Nielsen, H. M., Maae, E., Carlsen, D. & Mouridsen, H. T., Aug 2017, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 23, p. 2639-2646

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

    von Minckwitz, G., Procter, M., de Azambuja, E., Zardavas, D., Benyunes, M., Viale, G., Suter, T., Arahmani, A., Rouchet, N., Clark, E., Knott, A., Lang, I., Levy, C., Yardley, D. A., Bines, J., Gelber, R. D., Piccart, M., Baselga, J., APHINITY Steering Committee and Investigators (Michael Andersson, members) & Andersson, M., 13 Jul 2017, In : The New England journal of medicine. 377, 2, p. 122-131 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial

    Sonnenblick, A., Agbor-Tarh, D., Bradbury, I., Di Cosimo, S., Azim, H. A., Fumagalli, D., Sarp, S., Wolff, A. C., Andersson, M., Kroep, J., Cufer, T., Simon, S. D., Salman, P., Toi, M., Harris, L., Gralow, J., Keane, M., Moreno-Aspitia, A., Piccart-Gebhart, M. J. & de Azambuja, E., 1 May 2017, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 13, p. 1421-1429 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects

    Gilbert, E. S., Curtis, R. E., Hauptmann, M., Kleinerman, R. A., Lynch, C. F., Stovall, M., Smith, S. A., Weathers, R., Andersson, M., Dores, G. M., Fraumeni, J. F., Fossa, S. D., Hall, P., Hodgson, D. C., Holowaty, E. J., Joensuu, H., Johannesen, T. B., Langmark, F., Kaijser, M., Pukkala, E., Rajaraman, P., Storm, H. H., Vaalavirta, L., van den Belt-Dusebout, A. W., Aleman, B. M., Travis, L. B., Morton, L. M. & van Leeuwen, F. E., Feb 2017, In : Radiation Research. 187, 2, p. 186-195 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. 2016
  24. Published

    Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results

    Perez, E. A., López-Vega, J. M., Petit, T., Zamagni, C., Easton, V., Kamber, J., Restuccia, E. & Andersson, M., 13 Dec 2016, In : Breast Cancer Research. 18, 1, p. 126

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Risk of skin cancer following tamoxifen treatment in more than 16,000 breast cancer patients: a cohort study

    Praestegaard, C., Kjaer, S. K., Andersson, M., Steding-Jensen, M., Frederiksen, K. & Mellemkjaer, L., Nov 2016, In : Breast Cancer: Basic and Clinical Research. 23, 6, p. 908-916 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Increased pancreatic cancer risk following radiotherapy for testicular cancer

    Hauptmann, M., Børge Johannesen, T., Gilbert, E. S., Stovall, M., van Leeuwen, F. E., Rajaraman, P., Smith, S. A., Weathers, R. E., Aleman, B. M. P., Andersson, M., Curtis, R. E., Dores, G. M., Fraumeni, J. F., Hall, P., Holowaty, E. J., Joensuu, H., Kaijser, M., Kleinerman, R. A., Langmark, F., Lynch, C. F., Pukkala, E., Storm, H. H., Vaalavirta, L., van den Belt-Dusebout, A. W., Morton, L. M., Fossa, S. D. & Travis, L. B., 27 Sep 2016, In : B J C. 115, 7, p. 901-8 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Tailored nurse navigation for women treated for breast cancer: Design and rationale for a pilot randomized controlled trial

    Envold Bidstrup, P., Mertz, B. G., Kroman, N., Andersson, M., Mathiesen, U. B., Vibe-Petersen, J., Dalton, S. O. & Johansen, C., 25 May 2016, In : Acta oncologica . 55, 9-10, p. 1239-1243 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. 2015
  29. Published

    Increased stomach cancer risk following radiotherapy for testicular cancer

    Hauptmann, M., Fossa, S. D., Stovall, M., van Leeuwen, F. E., Johannesen, T. B., Rajaraman, P., Gilbert, E. S., Smith, S. A., Weathers, R. E., Aleman, B. M. P., Andersson, M., Curtis, R. E., Dores, G. M., Fraumeni, J. F., Hall, P., Holowaty, E. J., Joensuu, H., Kaijser, M., Kleinerman, R. A., Langmark, F., Lynch, C. F., Pukkala, E., Storm, H. H., Vaalavirta, L., van den Belt-Dusebout, A. W., Travis, L. B. & Morton, L. M., 6 Jan 2015, In : B J C. 112, 1, p. 44-51 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  30. 2014
  31. Published

    Incidence of metachronous contralateral breast cancer in Denmark 1978-2009

    Rasmussen, C. B., Kjær, S. K., Ejlertsen, B., Andersson, M., Jensen, M-B., Christensen, J., Langballe, R. & Mellemkjær, L., Dec 2014, In : International Journal of Epidemiology. 43, 6, p. 1855-64 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. 2013
  33. Published

    2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial

    Goldhirsch, A., Gelber, R. D., Piccart-Gebhart, M. J., de Azambuja, E., Procter, M., Suter, T. M., Jackisch, C., Cameron, D., Weber, H. A., Heinzmann, D., Dal Lago, L., McFadden, E., Dowsett, M., Untch, M., Gianni, L., Bell, R., Köhne, C-H., Vindevoghel, A., Andersson, M., Brunt, A. M., Otero-Reyes, D., Song, S., Smith, I., Leyland-Jones, B., Baselga, J. & Herceptin Adjuvant (HERA) Trial Study Team, 21 Sep 2013, In : Lancet. 382, 9897, p. 1021-8 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. Published

    Stomach cancer risk after treatment for hodgkin lymphoma

    Morton, L. M., Dores, G. M., Curtis, R. E., Lynch, C. F., Stovall, M., Hall, P., Gilbert, E. S., Hodgson, D. C., Storm, H. H., Johannesen, T. B., Smith, S. A., Weathers, R. E., Andersson, M., Fossa, S. D., Hauptmann, M., Holowaty, E. J., Joensuu, H., Kaijser, M., Kleinerman, R. A., Langmark, F., Pukkala, E., Vaalavirta, L., van den Belt-Dusebout, A. W., Fraumeni, J. F., Travis, L. B., Aleman, B. M. & van Leeuwen, F. E., 20 Sep 2013, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31, 27, p. 3369-77 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  35. Published

    Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report

    Bernstein, J. L., Thomas, D. C., Shore, R. E., Robson, M., Boice, J. D., Stovall, M., Andersson, M., Bernstein, L., Malone, K. E., Reiner, A. S., Lynch, C. F., Capanu, M., Smith, S. A., Tellhed, L., Teraoka, S. N., Begg, C. B., Olsen, J. H., Mellemkjaer, L., Liang, X., Diep, A. T., Borg, A., Concannon, P., Haile, R. W. & WECARE Study Collaborative Group, Sep 2013, In : European journal of cancer (Oxford, England : 1990). 49, 14, p. 2979-85 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. Published
  37. Published

    Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer

    Kleinerman, R. A., Smith, S. A., Holowaty, E., Hall, P., Pukkala, E., Vaalavirta, L., Stovall, M., Weathers, R., Gilbert, E., Aleman, B. M. P., Kaijser, M., Andersson, M., Storm, H. H., Joensuu, H., Lynch, C. F., Dores, G. M., Travis, L. B., Morton, L. M. & Curtis, R. E., 1 Aug 2013, In : International Journal of Radiation: Oncology - Biology - Physics. 86, 5, p. 922-9 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  38. Published

    Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial

    Oakman, C., Francis, P. A., Crown, J., Quinaux, E., Buyse, M., De Azambuja, E., Margeli Vila, M., Andersson, M., Nordenskjöld, B., Jakesz, R., Thürlimann, B., Gutiérrez, J., Harvey, V., Punzalan, L., Dell'orto, P., Larsimont, D., Steinberg, I., Gelber, R. D., Piccart-Gebhart, M., Viale, G. & Di Leo, A., May 2013, In : Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 24, 5, p. 1203-11 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published

    Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

    Nielsen, D. L., Kümler, I., Palshof, J. A. & Andersson, M., 2013, In : Breast. 22, 1, p. 1-12 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  40. 2012
  41. Published

    PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab

    Jensen, J. D., Knoop, A., Laenkholm, A. V., Grauslund, M., Jensen, M. B., Santoni-Rugiu, E., Andersson, M. & Ewertz, M., 2012, In : Annals of Oncology. 23, 8, p. 2034-42

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published

    Preoperative PET/CT in early-stage breast cancer

    Bernsdorf, M., Berthelsen, A. K., Timmermans-Wielenga, V., Kroman, N., Teilum, D., Binderup, T., Tange, U. B., Andersson, M., Kjær, A., Loft, A. & Graff, J., 2012, In : Annals of Oncology. 23, 9, p. 2277-82 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  43. Published

    Risk of treatment-related esophageal cancer among breast cancer survivors

    Morton, L. M., Gilbert, E. S., Hall, P., Andersson, M., Joensuu, H., Vaalavirta, L., Dores, G. M., Stovall, M., Holowaty, E. J., Lynch, C. F., Curtis, R. E., Smith, S., Kleinerman, R. A., Kaijser, M., Storm, H. H., Pukkala, E., Weathers, R. E., Linet, M. S., Rajaraman, P., Fraumeni, J. F., Brown, L. M., van Leeuwen, F. E., Fossa, S. D., Johannesen, T. B., Langmark, F., Lamart, S., Travis, L. B. & Aleman, B. M. P., 2012, In : Annals of Oncology. 23, 12, p. 3081-91 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  44. 2011
  45. Published

    Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group

    Nielsen, D. L., Bjerre, K. D., Jakobsen, E. H., Cold, S., Stenbygaard, L. E., Sørensen, P. G., Kamby, C., Møller, S., Jørgensen, C. L. T. & Andersson, M., Dec 2011, In : Journal of Clinical Oncology. 29, 36, p. 4748-54 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  46. Published

    Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer

    von Minckwitz, G., Schwedler, K., Schmidt, M., Barinoff, J., Mundhenke, C., Cufer, T., Maartense, E., de Jongh, F. E., Baumann, K. H., Bischoff, J., Harbeck, N., Lück, H-J., Maass, N., Zielinski, C., Andersson, M., Stein, R. C., Nekljudova, V., Loibl, S. & GBG 26/BIG 03-05 study group and participating investigators, Oct 2011, In : European Journal of Cancer. 47, 15, p. 2273-81 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  47. Published

    Risk of primary non-breast cancer after female breast cancer by age at diagnosis

    Mellemkjær, L., Christensen, J., Frederiksen, K. S., Pukkala, E., Weiderpass, E., Bray, F., Friis, S., Andersson, M. & Olsen, H. J., Aug 2011, In : Cancer Epidemiology, Biomarkers & Prevention. 20, 8, p. 1784-92 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  48. Published

    Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1

    Edlund, P., Ahlgren, J., Bjerre, K., Andersson, M., Bergh, J., Mouridsen, H., Holmberg, S. B., Bengtsson, N-O., Jakobsen, E. W., Møller, S., Lindman, H. & Blomqvist, C., Apr 2011, In : Acta Oncologica. 50, 3, p. 329-37 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    Risk for second primary non-breast cancer in pre- and postmenopausal women with breast cancer not treated with chemotherapy, radiotherapy or endocrine therapy

    Langballe, R., Olsen, H. J., Andersson, M. & Mellemkjær, L., Apr 2011, In : European Journal of Cancer. 47, 6, p. 946-52 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  50. Published

    Supraclavicular recurrence after early breast cancer: a curable condition?

    Pedersen, A. N., Møller, S., Dahl Steffensen, K., Haahr, V., Jensen, M., Kempel, M. M., Jepsen, S., Madsen, E. L., Roslind, A., Sandberg, E., Schöllkopf, C., Sørensen, P. G., Windfeldt, K. M. & Andersson, M., 1 Feb 2011, In : Breast Cancer Research and Treatment. 125, 3, p. 815-22 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  51. Published

    Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study

    Andersson, M., Lidbrink, E., Bjerre, K., Wist, E., Enevoldsen, K., Jensen, A., Karlsson, P. W., Tange, U. B., Sørensen, M. P., Møller, S., Bergh, J. & Langkjer, S. T., Jan 2011, In : Journal of Clinical Oncology. 29, 3, p. 264-71 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  52. 2010
  53. Published

    Antiangiogenic therapy for breast cancer

    Nielsen, D. L., Andersson, M., Andersen, J. A. L. & Kamby, C., 2010, In : Breast Cancer Research (Online Edition). 12, 5, p. 209 1 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  54. Published

    Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer

    Ejlertsen, B., Mouridsen, H. T., Jensen, M. B., Andersen, J., Andersson, M., Kamby, C. & Knoop, A., 2010, In : Cancer. 116, 9, p. 2081-9 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 26012